Omeros (OMER) - Analyst EPS View

Omeros (OMER) – Analyst EPS View

May 18, 2022 07:43 AM Omeros Corp's (OMER) Narsoplimab Approval Pathway is More Challenging, PT Lowered to $12 at BofA Securities
Aug 2, 2017 03:44 PM Omeros Corp. (OMER) PT Raised to $24 at Maxim Group Into Results
Jun 13, 2017 12:39 PM
Mar 30, 2017 10:44 AM
Mar 28, 2017 12:11 PM
Mar 17, 2017 07:54 AM
Mar 17, 2017 07:46 AM
Mar 17, 2017 06:24 AM
Nov 10, 2016 07:04 AM
Mar 8, 2016 12:21 PM
Nov 11, 2015 06:41 AM
Nov 10, 2015 02:18 PM
Mar 17, 2015 07:17 AM
Nov 13, 2014 07:27 AM
Oct 2, 2013 10:57 AM
Sep 16, 2013 10:08 AM
May 23, 2013 01:37 PM
Mar 26, 2013 12:00 PM